share_log

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alyeska Investment Group, L.P.(0.0%),Alyeska Fund GP, LLC(0.0%), etc.

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alyeska Investment Group, L.P.(0.0%),Alyeska Fund GP, LLC(0.0%), etc.

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-Alyeska Investment Group, L.P.(0.0%),Alyeska Fund GP, LLC(0.0%)等
美股SEC公告 ·  11/14 16:45

Moomoo AI 已提取核心信息

Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have filed an amended Schedule 13G/A with the United States Securities and Exchange Commission, indicating that they no longer beneficially own more than five percent of bluebird bio, Inc.'s common stock. The filing, dated September 30, 2024, shows that each reporting person now owns 0% of the company's common stock, effectively ceasing their status as major shareholders. The addresses for all reporting persons are listed as 77 West Wacker Drive, 7th Floor, Chicago, IL 60601. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, with Alyeska Investment Group and Alyeska Fund GP, LLC classified as investment advisers and parent holding companies or control persons. The certification signed by Jason Bragg, Chief Financial Officer for both Alyeska entities, and Anand Parekh individually, asserts that the shares were acquired and held in the ordinary course of business and not for the purpose of changing or influencing the control of bluebird bio, Inc.
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have filed an amended Schedule 13G/A with the United States Securities and Exchange Commission, indicating that they no longer beneficially own more than five percent of bluebird bio, Inc.'s common stock. The filing, dated September 30, 2024, shows that each reporting person now owns 0% of the company's common stock, effectively ceasing their status as major shareholders. The addresses for all reporting persons are listed as 77 West Wacker Drive, 7th Floor, Chicago, IL 60601. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, with Alyeska Investment Group and Alyeska Fund GP, LLC classified as investment advisers and parent holding companies or control persons. The certification signed by Jason Bragg, Chief Financial Officer for both Alyeska entities, and Anand Parekh individually, asserts that the shares were acquired and held in the ordinary course of business and not for the purpose of changing or influencing the control of bluebird bio, Inc.
Alyeska Investment Group, L.P.，Alyeska Fund GP, LLC 和Anand Parekh已向美国证券交易委员会递交了修订后的13G/A表格，表明他们不再持有bluebird bio, Inc.的普通股超过5%。文件日期为2024年9月30日，显示每位报告人现在持有该公司的普通股为0%，有效地终止了他们作为主要股东的地位。所有报告人的地址均列为77 West Wacker Drive, 7th Floor, Chicago, IL 60601。该申报根据1934年证券交易法第13d-1(b)条进行，Alyeska Investment Group 和Al...展开全部
Alyeska Investment Group, L.P.，Alyeska Fund GP, LLC 和Anand Parekh已向美国证券交易委员会递交了修订后的13G/A表格，表明他们不再持有bluebird bio, Inc.的普通股超过5%。文件日期为2024年9月30日，显示每位报告人现在持有该公司的普通股为0%，有效地终止了他们作为主要股东的地位。所有报告人的地址均列为77 West Wacker Drive, 7th Floor, Chicago, IL 60601。该申报根据1934年证券交易法第13d-1(b)条进行，Alyeska Investment Group 和Alyeska Fund GP, LLC被列为投资顾问和母公司或受控人。由Alyeska的首席财务官Jason Bragg和Anand Parekh分别签署的证书声明这些股份是在正常业务过程中收购和持有的，并非出于改变或影响bluebird bio, Inc控制权的目的。

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间